Your Web Site
ImClone accepts $6 billion-plus buyout bid from Lilly; Bristol-Myers won't raise offer
By TOM MURPHY , Associated Press INDIANAPOLIS - Eli Lilly & Co. has agreed to spend more than $6 billion to fortify its cancer treatment portfolio by acquiring the biotechnology firm ImClone Systems Inc. in a deal that tops...
